Inactive Instrument

Mesco Pharmaceuticals Limited

Equities

500274

INE839X01015

Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020

February 13, 2021 at 11:06 am IST

Mesco Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced net loss was INR 6,000 compared to INR 11,942.82 a year ago. For the nine months, net loss was INR 18,029.5 compared to INR 122,670.82 a year ago. Basic loss per share from continuing operations was INR 0.01 compared to INR 0.06 a year ago.

Latest news about Mesco Pharmaceuticals Limited

Mesco Pharmaceuticals Widens Net Loss in Fiscal Q3	18/22/18	MT
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	17/22/17	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	01/21/01	CI
Mesco Pharmaceuticals Limited Announces Resignation of Savita Sethi as Independent Director	09/21/09	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	13/21/13	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/20/12	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	31/20/31	CI
Mesco Pharmaceuticals Limited Appoints Dhruv Singh as Chief Executive Officer	31/20/31	CI
Mesco Pharmaceuticals Limited Appoints Dhruv Singh as an Additional Director on the Board of the Company	31/20/31	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	13/20/13	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	15/19/15	CI
Mesco Pharmaceuticals Limited Announces Demise of Jitendra Kumar Singh, Non-Executive and Non Independent Director	09/19/09	CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	14/19/14	CI
Mesco Pharmaceuticals Limited Appoints Hawa Singh Chahar as an Additional Director (Non-Executive Independent Director)	21/19/21	CI
Mesco Pharmaceuticals Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019	28/19/28	CI
Mesco Pharmaceuticals Limited Appoints Varinder Prakash as an Additional Director	28/19/28	CI
Mesco Pharmaceuticals Announces Management Changes	27/19/27	CI
Mesco Pharmaceuticals Limited Announces Resignation of Subash Chander Seth as Non-Executive, Independent Director	01/19/01	CI
Mesco Pharmaceuticals Limited Announces Change in Management	25/19/25	CI
Mesco Pharmaceuticals Limited Reports Unaudited Earnings Results for the Quarter and Nine Months Ended December 31, 2018	13/19/13	CI
Mesco Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	14/18/14	CI
Mesco Pharmaceuticals Ltd Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2018	14/18/14	CI
Mesco Pharmaceuticals Ltd Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018	30/18/30	CI
Mesco Pharmaceuticals Ltd Announces Management Changes	03/18/03	CI

Chart Mesco Pharmaceuticals Limited

Duration

Period

More charts

Company Profile

Sector

More about the company